| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15:54 | IceCure Medical to boost share price with 1-for-30 reverse split to regain Nasdaq compliance | 1 | Seeking Alpha | ||
| ICECURE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 14:45 | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14:30 | IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance | 44 | PR Newswire | Proactive Step to Regain Nasdaq Compliance as Part of the Company's Broader Capital Markets Strategy
CAESAREA, ISRAEL, June 2, 2026 /PRNewswire/ -- IceCure Medical... ► Artikel lesen | |
| 19.05. | IceCure Medical: IceCure's ProSense Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked | 155 | PR Newswire | At the annual European Conference on Interventional Oncology, ICESECRET data presented demonstrated 89.4% recurrence-free rate in patients with tumors =3 cm and... ► Artikel lesen | |
| 13.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 13.05. | IceCure Medical: IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement | 238 | PR Newswire | No Immediate Effect on Nasdaq Listing or Trading of the Company's Ordinary Shares
CAESAREA, Israel, May 13, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM)... ► Artikel lesen | |
| 12.05. | IceCure Medical GAAP EPS of $0.06, revenue of $911M | 3 | Seeking Alpha | ||
| 12.05. | IceCure Medical Ltd Q1 Sales Increase | 1 | RTTNews | ||
| 12.05. | IceCure Medical: IceCure Reports First Quarter 2026 Financial Results: ProSense Sales Increase Substantially in the U.S. and North America | 307 | PR Newswire | Pent-up demand immediately following FDA clearance generates 46% increase in active customer accounts using ProSense® as of the end of the first quarter 2026, compared... ► Artikel lesen | |
| 10.05. | Quant snapshot: Beachbody, Deutsche Telekom among top-rated names as IceCure Medical, Fold Holdings lag | 31 | Seeking Alpha | ||
| 06.05. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 21.04. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 01.04. | IceCure Medical Ltd. - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 26.03. | IceCure prices $4M direct offering, concurrent private placement | 2 | Seeking Alpha | ||
| 25.03. | IceCure Medical Reports Positive Trial Results For ProSense Cryoablation System | 2 | RTTNews | ||
| 24.03. | IceCure Medical: IceCure Appoints Meir Peleg as Chief Financial Officer | 199 | PR Newswire | Meir Peleg brings over 20 years of financial leadership and experience including with Nasdaq listed companiesIceCure intends to appoint Dr. Richard Fine as Medical Director CAESAREA, Israel... ► Artikel lesen | |
| 24.03. | IceCure Medical Appoints Meir Peleg As CFO; Shares Rise In Pre-market | - | RTTNews | ||
| 24.03. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 17.03. | IceCure Medical: IceCure Reports 2025 Full Year Financial & Operational Results | 403 | PR Newswire | Record 4th quarter and full year sales of $1.3 million and $3.4 million, respectively
Strong commercial momentum for ProSense® in the U.S. and globally following... ► Artikel lesen | |
| 17.03. | IceCure Medical Ltd Profit Drops In Full Year | - | RTTNews |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 4,805 | -1,84 % | Plus Therapeutics Inc.: Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases | ||
| ORGANON | 11,475 | -0,22 % | Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia | SEOUL, South Korea, May 21, 2026 (GLOBE NEWSWIRE) -- Hanmi Pharmaceutical announced that it has signed a supply agreement with global healthcare company Organon to export three combination medicines... ► Artikel lesen | |
| CO-DIAGNOSTICS | 7,660 | +23,55 % | Is Co-Diagnostics National Security's Next Diagnostic Pick? | ||
| SENSEONICS | 6,050 | +2,54 % | Senseonics Holdings, Inc.: Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026 | ||
| VIRIDIAN THERAPEUTICS | 14,400 | -1,37 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
| INSPIRE MEDICAL SYSTEMS | 36,000 | +2,27 % | What Does Stifel Think About Inspire Medical (INSP) After a Guidance Cut That Surprised Wall Street? | ||
| VYOME | 2,350 | +1,29 % | Vyome Holdings, Inc. reports Q1 results | ||
| EMBECTA | 2,885 | +1,84 % | Dividendenbekanntmachungen (28.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACTIVIA PROPERTIES INC JP3047490002 3169 JPY 17,0809 EUR ADVANCED MEDICAL SOLUTIONS GROUP PLC GB0004536594 0,0201 GBP 0,0232 EUR AIA... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 26,680 | -4,24 % | Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment | ||
| AXOGEN | 33,390 | +0,24 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| TACTILE SYSTEMS TECHNOLOGY | 21,760 | +5,53 % | Tactile Systems Technology, Inc.: Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio | MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (Nasdaq: TCMD), a medical technology company providing therapies for people with... ► Artikel lesen | |
| APYX MEDICAL | 3,320 | -1,19 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| GLAUKOS | 89,50 | +0,56 % | Glaukos - GKOS: Pullback-Setup mit Unterstützung bei 130 USD! | Starkes Wachstum erwartet! Aber Achtung: Insider verkaufen Glaukos-Aktien (GKOS) im Wert von 4.2 Millionen USD! Glaukos (GKOS) - US3773221029 Rückblick: Aufgrund der stark überkauften Situation am US-Gesamtmarkt... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,620 | +0,58 % | Lexaria Bioscience Corp.: Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 | KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, is pleased to announce that ethics... ► Artikel lesen | |
| ITONIC | 0,304 | 0,00 % | iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule | BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other... ► Artikel lesen |